Lugar de publicación

• Evaluation of serological assays to monitor antibody responses to single-dose HPV vaccines.  38:5997-6006. 2020
• Acute otitis media, antimicrobial prescriptions, and medical expenses among children in the United States during 2011–2016.  36:7479-7486. 2018
• Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies.  36:4774-4782. 2018
• Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women.  150:201-215. 2017
• Rationale and design of a long term follow-up study of women who did and did not receive HPV 16/18 vaccination in Guanacaste, Costa Rica.  33:2141-2151. 2015
• Safety of a quadrivalent meningococcal serogroups A, C, W and Y conjugate vaccine (MenACWY-CRM) administered with routine infant vaccinations: Results of an open-label, randomized, phase 3b controlled study in healthy infants.  32:965-972. 2014
• Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica.  30:2342-2348. 2012
• Streptococcus pneumoniae serotypes isolated from the middle ear fluid of Costa Rican children following introduction of the heptavalent pneumococcal conjugate vaccine into a limited population.  30:3857-3861. 2012
• Prevenar experience.  29:C26-C34. 2011
• The use of green fluorescent protein as a marker for Brucella vaccines.  29:577-582. 2011
• Safety and immunogenicity of one dose of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, when administered to adolescents concomitantly or sequentially with Tdap and HPV vaccines.  28:3171-3179. 2010
• Neutralization of venom-induced hemorrhage by equine antibodies raised by immunization with a plasmid encoding a novel P-II metalloproteinase from the lancehead pitviper Bothrops asper.  27:460-466. 2009